Executive Directors

Policy on external appointments

The Committee believes that the experience gained by allowing executive directors to serve as non-executive directors on the boards of other organisations is of benefit to Reed Elsevier. Accordingly, executive directors may, subject to the approval of the Chairman and the Chief Executive Officer, serve as non-executive directors on the boards of up to two non-associated companies (of which only one may be to the board of a major company) and they may retain remuneration arising from such appointments.

• Gerard van de Aast is a non-executive director of OCE NV and received a fee of euro 44,723 (£35,494) during 2008 (euro 37,216 (£25,490) during 2007).
• Sir Crispin Davis is a non-executive director of GlaxoSmithKline plc and received a fee of £86,250 during 2008 (£70,000 during 2007).
• Andrew Prozes is a non-executive director of the Cott Corporation and received a fee of US$153,790 (£83,130) during 2008 (US$62,270 (£31,135) during 2007).